The role of lysophosphatidic acid metabolism in castration-resistant prostate cancer progression

Prostate cancer (PCa) is a leading malignancy in men, with mortality primarily attributed to progression to castration-resistant prostate cancer (CRPC). Although androgen deprivation therapy (ADT) initially demonstrates efficacy, most advanced patients eventually develop CRPC—a stage characterized b...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Jinpeng Feng, Jiale Liu, Yi He
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2026-05-01
Edice:	Frontiers in Oncology
Témata:	castration resistance lysophosphatidic acid metabolic reprogramming prostate cancer targeted therapy
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fonc.2026.1842091/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!